June 30, 2022 | Issue #8

Good evening

. Today marks just the 8th issue of our newsletter series as our roadmap here at spannr continues. Thanks again for subscribing and be sure to

check out our archive

in case you're just now joining us.

As always, give us a shout by simply hitting reply in your inbox – we'd love to hear your feedback.

Barking Up the Right Tree: How Dogs Just Might Be the Key to Human Longevity

Since dogs were first domesticated roughly 30,000 years ago, they have helped humans navigate through life’s hardships in various ways.From hunting and gathering to helping owners alleviate stress and depression, ease loneliness, and even encourage exercise, dogs certainly play a large role in one’s health and happiness.Today, however, they are beginning to help humans in ways unimaginable; by helping the scientific community take on longevity.While billions of dollars have recently been earmarked to focus on aging interventions for humans, a small group of companies are taking on age-related disease by first focusing on our most faithful companions – dogs.In our latest research, we explore which companies are leading the way, the clinical advantages dogs have over mice, and how aging research on our pets could change the longevity industry as we know it. Continue reading >>

• Molecule DAO raises $12.7 million in seed round led by Northpond Ventures

• NOWATCH Raises $8.7 million for its stress-sensing wearable

• Vibe Biotechnology announces $12 million in funding to advance its community-driven approach to identifying and developing treatments for rare diseases

• Bolden Therapeutics receives ~$500,000 grant from the NIA to support the development of antisense oligonucleotides to promote neurogenesis

• MyOme Secures $23 Million in Series B funding to deliver clinical whole genome insights

• btt Corp. raises $29.3 Million to deploy diagnostic and treatment technologies based on brain thermodynamics and thermoregulatory frequencies

• University of New Mexico team gets extended $3 million grant to study aging in chimps

• Cyclarity Therapeutics has Moved to the Buck Institute for Research on Aging

• Stealth BioTherapeutics could get even sneakier with Morningside's go-private deal pitch

• Nucleate announces expansion to new regions in the United States and Europe

• Genflow Biosciences Research Agreement Signed with Magnitude Biosciences Limited

• Ora Biomedical: Dog Aging Project's & Loyal's Matt Kaeberlein Starting New Longevity Biotech Company

• Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.

• Geron Corporation Announces Expansion of Existing Loan Facility

• Lento Bio, An Ichor Life Sciences Portfolio Company, Launches with Aims to Develop Anti-Glycation Drugs for Presbyopia and Diseases of Aging

• Precision BioSciences Announces Closing of Underwritten Offering of Common Stock

• UNITY Biotechnology Reports Granting of New Employment Inducement Award